Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 77551-77600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05669872
Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer
NA
Not yet recruiting
334 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05803343
Evaluating Additive Effects of Including Canines in Regulating Together
PHASE2
Recruiting
240 participants
Started: Feb 28, 2023 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT06826820
Fertility: Infection and Inflammation
N/A
Recruiting
800 participants
Started: Feb 28, 2023 · Completed: Dec 20, 2032
1 condition
1 sponsor
1 location
NCT05721573
A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis
PHASE2/PHASE3
Active, not recruiting
231 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
45 locations
NCT05744479
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
PHASE4
Recruiting
100 participants
Started: Feb 28, 2023 · Completed: Dec 1, 2026
3 conditions
1 sponsor
1 location
NCT05691114
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease
PHASE1
Recruiting
18 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05750576
Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
NA
Not yet recruiting
270 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
0 locations
NCT06699017
Effect of Continuous Anterior Chest Compression on Ventilation/Perfusion Ratio and Hemodynamics
NA
Recruiting
20 participants
Started: Feb 28, 2023 · Completed: May 30, 2025
1 condition
1 sponsor
1 location
NCT05774938
QoL After Complex Endovascular Aortic Repair
N/A
Recruiting
90 participants
Started: Feb 28, 2023 · Completed: Jan 31, 2030
3 conditions
1 sponsor
1 location
NCT06597838
Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
N/A
Recruiting
161,876 participants
Started: Feb 28, 2023 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT05715931
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
PHASE2
Recruiting
30 participants
Started: Feb 28, 2023 · Completed: Mar 1, 2028
3 conditions
1 sponsor
8 locations
NCT06344962
Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection
NA
Recruiting
40 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05712707
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
PHASE1/PHASE2
Active, not recruiting
160 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2025
2 conditions
6 sponsors
4 locations
NCT05658523
COVID-19 Booster Study in Healthy Adults in Australia
PHASE3
Active, not recruiting
497 participants
Started: Feb 28, 2023 · Completed: Oct 31, 2024
1 condition
3 sponsors
1 location
NCT06051136
Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer
NA
Active, not recruiting
40 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05516628
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
PHASE2
Recruiting
30 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2027
1 condition
14 sponsors
6 locations
NCT05445648
Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer
PHASE2
Not yet recruiting
65 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05709626
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
PHASE4
Recruiting
2,258 participants
Started: Feb 28, 2023 · Completed: Jan 4, 2028
1 condition
2 sponsors
1 location
NCT05641493
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation
PHASE1/PHASE2
Recruiting
49 participants
Started: Feb 28, 2023 · Completed: Feb 27, 2026
1 condition
1 sponsor
1 location
NCT05566223
CISH Inactivated TILs in the Treatment of NSCLC
PHASE1/PHASE2
Not yet recruiting
70 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2027
6 conditions
1 sponsor
2 locations
NCT05765929
Use of Weightbearing Radiographs to Determine Treatment of bi- and Trimalleolar Ankle Fractures
NA
Recruiting
29 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2032
2 conditions
1 sponsor
1 location
NCT05712473
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
N/A
Not yet recruiting
500 participants
Started: Feb 28, 2023 · Completed: Jun 30, 2029
1 condition
2 sponsors
0 locations
NCT05664139
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
PHASE2
Not yet recruiting
30 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
2 conditions
3 sponsors
0 locations
NCT05704218
Hypersensitivity Pneumonitis of Domestic Origin
NA
Not yet recruiting
500 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2026
3 conditions
1 sponsor
0 locations
NCT05760391
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
NA
Recruiting
100 participants
Started: Feb 28, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06430125
Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus
PHASE3
Recruiting
46 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT04761146
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
NA
Recruiting
10 participants
Started: Feb 28, 2023 · Completed: Jan 1, 2026
3 conditions
2 sponsors
1 location
NCT05798117
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
PHASE1/PHASE2
Active, not recruiting
21 participants
Started: Feb 28, 2023 · Completed: Sep 9, 2026
2 conditions
1 sponsor
12 locations
NCT05738707
Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
N/A
Not yet recruiting
100 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition
1 sponsor
0 locations
NCT05434273
Effects of Integrated Cardiovascular Health Education Program on Older Adults at Risk of ASCVD
NA
Not yet recruiting
190 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT05650710
Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation
NA
Recruiting
50 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05715398
BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer
PHASE1/PHASE2
Not yet recruiting
90 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
NCT05443594
A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation
NA
Active, not recruiting
669 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
44 locations
NCT04900792
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
PHASE1
Active, not recruiting
17 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05745454
A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors
NA
Not yet recruiting
12 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
NCT05698992
Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer
N/A
Recruiting
100 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2027
4 conditions
2 sponsors
1 location
NCT05666713
NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial
NA
Active, not recruiting
139 participants
Started: Feb 27, 2023 · Completed: May 14, 2025
2 conditions
1 sponsor
10 locations
NCT05734729
Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes
NA
Recruiting
120 participants
Started: Feb 27, 2023 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05626426
Electrical Stimulation for the Treatment of Optic Neuropathies
NA
Recruiting
40 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT05819229
Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection
N/A
Recruiting
125 participants
Started: Feb 27, 2023 · Completed: May 1, 2025
1 condition
2 sponsors
4 locations
NCT05847855
Multi-dimensional Fragmentomic Assay for Early Detection of Pancreatic Neuroendocrine Tumors
N/A
Recruiting
440 participants
Started: Feb 27, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06092437
Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients
NA
Recruiting
466 participants
Started: Feb 27, 2023 · Completed: Aug 27, 2026
1 condition
1 sponsor
2 locations
NCT06073535
The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction
NA
Active, not recruiting
40 participants
Started: Feb 27, 2023 · Completed: Dec 29, 2023
2 conditions
1 sponsor
1 location
NCT05752318
Analysis of the Persistence, Reservoir and HIV Latency
N/A
Not yet recruiting
500 participants
Started: Feb 27, 2023 · Completed: Feb 25, 2027
2 conditions
1 sponsor
0 locations
NCT05666960
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
PHASE1
Recruiting
36 participants
Started: Feb 27, 2023 · Completed: Oct 31, 2025
4 conditions
3 sponsors
3 locations
NCT06534944
NAD Supplementation and Vascular Health in PAD
PHASE1/PHASE2
Active, not recruiting
8 participants
Started: Feb 27, 2023 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT05355363
Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay
NA
Recruiting
730 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05226663
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer
PHASE2
Recruiting
36 participants
Started: Feb 27, 2023 · Completed: Aug 20, 2026
1 condition
3 sponsors
3 locations
NCT05605379
CML Pediatric ITK Response According to Molecular Identification at Diagnosis
N/A
Recruiting
88 participants
Started: Feb 27, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT06346119
Evaluation of the Impact of Touch Relaxation in Sedated Intubated Patients Hospitalized in Intensive Care at Niort Hospital
NA
Recruiting
72 participants
Started: Feb 27, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
Previous
1
More pages
1549
1550
1551
1552
1553
1554
1555
More pages
2369
Next